• About us
• Contact

Advertisement

Product › Details

cancer drug

	Next higher product group	pharmaceutical
	Status	1998-01-01 sales existent

Record changed: 2025-03-23

Advertisement

More documents for cancer drug

• [1] Araris Biotech AG. (3/17/25). "Press Release: Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech"....
• [2] AstraZeneca plc. (3/17/25). "Press Release: AstraZeneca Enters License Agreement with Alteogen for Subcutaneous Formulations of Multiple Oncology Assets"....
• [3] Sun Pharmaceutical Industries Ltd.. (3/10/25). "Press Release: Sun Pharma to Acquire Checkpoint Therapeutics". Mumbai & Waltham, MA....
• [4] Valo Therapeutics Oy. (3/10/25). "Press Release: Valo Therapeutics Announces EUR 19m of Investment Funding and Expanded Clinical Trials". Helsinki, Naples & Perth....
• [5] Callio Therapeutics. (3/3/25). "Press Release: Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept". Seattle, WA & Singapore....
• [6] FibroGen, Inc.. (2/20/25). "Press Release: FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million". San Francisco, CA....
• [7] Eckert & Ziegler SE. (1/14/25). "Press Release: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture". Berlin....
• [8] BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg....
• [9] Daiichi Sankyo Co., Ltd.. (1/13/25). "Press Release: Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH". Tokyo & Basking Ridge, NJ....
• [10] Eckert & Ziegler SE. (1/13/25). "Press Release: Eckert & Ziegler and GlyTherix Extend Collaboration with Actinium-225 Supply Agreement". Berlin & Sydney....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.